Package Leaflet: Information for the User
Kaptic100 micrograms sublingual tablets EFG
Kaptic200 micrograms sublingual tablets EFG
Kaptic300 micrograms sublingual tablets EFG
Kaptic400 micrograms sublingual tablets EFG
Kaptic600 micrograms sublingual tablets EFG
Kaptic800 micrograms sublingual tablets EFG
Fentanyl
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Kaptic is a treatment for adults who are already taking regular, potent pain medicines (opioids)for their persistent cancer pain, but who need treatment for breakthrough pain. If you are not sure, consult your doctor.
Breakthrough pain is a type of pain that comes on suddenly, even when you have taken your usual opioid pain medicine.
The active substance in Kaptic sublingual tablets is fentanyl. Fentanyl belongs to a group of strong pain-relieving medicines called opioids.
Do not take Kaptic
Warnings and precautions
Tell your doctor or pharmacist or nurse before you start taking Kaptic if you have or have had any of the following conditions, as your doctor will need to take this into account when prescribing your dose:
When taking Kaptic, tell your doctor or dentist that you are taking this medicine, if:
It is possible that your doctor will need to monitor you more closely:
Use in athletes
This medicine contains fentanyl, which may produce a positive result in doping tests.
Other medicines and Kaptic
Tell your doctor or pharmacist that you are using or have recently used or may need to use any other medicine (other than the opioid medicines you take regularly for pain).
Some medicines may increase or decrease the effects of Kaptic. Consequently, if you start, change the dose, or stop treatment with the following medicines, tell your doctor, as they may need to adjust your dose of Kaptic.
The following medicines may increase the effects of Kaptic:
The following medicines may reduce the effects of Kaptic:
Kaptic may increase the effect of medicines that make you feel sleepy, so concurrent use increases the risk of drowsiness, difficulty breathing (respiratory depression), coma, and can put your life at risk. Therefore, concurrent use should only be considered when there are no other possible treatment alternatives.
Some examples of sedative medicines are:
However, if your doctor prescribes Kaptic and sedative medicines at the same time, the dose and duration of treatment should be limited by your doctor.
Tell your doctor about all sedative medicines you are taking and follow the recommended dose strictly as prescribed by your doctor. It may be useful to inform your family or friends about the signs and symptoms mentioned above. Talk to your doctor if you experience any of these symptoms.
The risk of side effects increases if you are taking medicines such as certain antidepressants or antipsychotics. Kaptic may interact with these medicines, and you may experience changes in mental status (e.g., agitation, hallucinations, coma) and other effects such as body temperature above 38°C, increased heart rate, unstable blood pressure, and exaggerated reflexes, muscle stiffness, lack of coordination, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea). Your doctor will tell you if Kaptic is suitable for you.
Concomitant use of Kaptic with medicines called monoamine oxidase inhibitors (MAOIs), used to treat severe depression and Parkinson's disease, is not recommended. Tell your doctor if you have taken this type of medicine in the last two weeks.
Using Kaptic with food, drinks, and alcohol
Kaptic may cause drowsiness in some people. Do not drink alcohol without consulting your doctor, as it may make you feel more drowsy than usual.
Do not drink grapefruit juice during treatment with Kaptic, as it may increase the adverse effects of Kaptic.
Pregnancy and breastfeeding
Do not take Kaptic during pregnancy unless your doctor has explicitly told you to do so.
Fentanyl can pass into breast milk and cause side effects in the breastfed baby. Do not use Kaptic if you are breastfeeding. You should not start breastfeeding until at least 5 days after the last dose of Kaptic.
Ask your doctor or pharmacist for advice before taking any medicine during pregnancy or breastfeeding.
Driving and using machines
Ask your doctor if you can drive or use machines while taking Kaptic. It is essential that you observe how this medicine affects you before driving or using machines. Do not drive or use machines if you feel drowsy, dizzy, have blurred vision, or double vision, or have difficulty concentrating. Be particularly careful at the start of treatment, after a dose increase, after a change in formulation, and/or when taking it with other medicines.
Before taking Kaptic for the first time, your doctor will explain how to take it to effectively treat your breakthrough pain.
Follow the instructions for taking this medicine exactly as prescribed by your doctor. If you are unsure, consult your doctor or pharmacist again.
YOU SHOULD ONLY USE THIS MEDICINE AS DIRECTED BY YOUR DOCTOR.Do not use it for anyone else, as it could cause serious health risks, especially in children.
Kaptic is a different type of medicine from other pain medicines you may have used. ALWAYS TAKE THE DOSE OF KAPTIC AS DIRECTED BY YOUR DOCTOR;this may be a different dose from the one you used with other pain medicines for breakthrough pain.
Starting treatment – Finding the right dose
For Kaptic treatment to be successful, your doctor will need to find the right dose to treat your breakthrough pain. Kaptic is available in a range of doses. You may need to try different doses of Kaptic during different episodes of pain before finding the right dose. Your doctor will help you with this and find the right dose for you.
If you do not get adequate pain relief with a dose, your doctor may tell you to take an additional dose to treat a breakthrough pain episode. DO NOT TAKE A SECOND DOSE UNLESS YOUR DOCTOR TELLS YOU TO,as you may experience an overdose.
Your doctor may advise you to take a dose consisting of more than one tablet at the same time. ONLY DO THIS IF YOUR DOCTOR TELLS YOU TO.
After taking the last dose, wait at least two hours before treating the next breakthrough pain episode with Kaptic.
Continuing treatment – Once the right dose is established
Once you and your doctor have established a dose of Kaptic that controls your breakthrough pain, you should not take this dose more than four times a day. A DOSE OF KAPTIC MAY CONSIST OF MORE THAN ONE TABLET.
After taking the last dose, wait at least two hours before treating the next breakthrough pain episode with Kaptic.
If you think the dose of Kaptic you are using does not control your breakthrough pain satisfactorily, tell your doctor, as you may need a dose adjustment.
Do not change your dose of Kaptic unless your doctor tells you to.
Taking the medicine
Kaptic should be used sublingually. This means you should place the tablet under your tongue, where it will dissolve quickly to allow fentanyl to be absorbed through the lining of your mouth. Once absorbed, fentanyl starts to work to relieve pain.
When you have a breakthrough pain episode, take the dose prescribed by your doctor as follows:
If you take more Kaptic than you should
The symptoms of an overdose include:
If this happens, seek medical help immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you stop taking Kaptic
You should stop using Kaptic when you no longer have breakthrough pain. However, you should continue taking your usual opioid medicines for persistent cancer pain as recommended by your doctor. You may experience withdrawal symptoms similar to the possible side effects of Kaptic when you stop treatment with Kaptic. If you have withdrawal symptoms or are concerned about pain relief, consult your doctor, who will assess whether you need any medicine to reduce or suppress withdrawal symptoms.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Kaptic can cause adverse effects, although not all people suffer from them.
If you start to feel unusual or extreme drowsiness or your breathing becomes shallow and slow, you or your caregiver should contact your doctor or local hospital to seek emergency help (see also section 3 "If you take more Kaptic than you should").
Very common adverse effects (may affect more than 1 in 10 people) include:
Common adverse effects (may affect up to 1 in 10 people) include:
Uncommon adverse effects (may affect up to 1 in 100 people):
Adverse effects of unknown frequency (frequency cannot be estimated from available data):
Prolonged treatment with fentanyl during pregnancy may cause withdrawal symptoms in the newborn, which can be potentially fatal (see section 2).
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
The pain relief of this medicine is very strong and can be extremely dangerous if a child were to take it accidentally. Keep out of sight and reach of children.
Do not use this medicine after the expiration date stated on the blister pack after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
It is recommended to store Kaptic in a closed or locked place.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Kaptic Composition
The active ingredient is fentanyl. Each sublingual tablet contains:
100 micrograms of fentanyl (as citrate)
200 micrograms of fentanyl (as citrate)
300 micrograms of fentanyl (as citrate)
400 micrograms of fentanyl (as citrate)
600 micrograms of fentanyl (as citrate)
800 micrograms of fentanyl (as citrate)
The other ingredients are mannitol (E421), silicified microcrystalline cellulose, sodium croscarmellose, and magnesium stearate.
Product Appearance and Package Contents
Kaptic is a small white sublingual tablet that should be placed under the tongue. It is available in a wide range of doses and forms. Your doctor will prescribe the appropriate dose (form) and number of tablets for you.
The 100 microgram tablet is a white, round tablet
The 200 microgram tablet is a white, oval tablet
The 300 microgram tablet is a white, triangular tablet
The 400 microgram tablet is a white, diamond-shaped tablet
The 600 microgram tablet is a white, D-shaped tablet
The 800 microgram tablet is a white, capsule-shaped tablet
Kaptic 100, 200, 300, 400 micrograms is available in packs of 10x1 or 30x1 tablets in a precut unit dose blister.
Kaptic 600, 800 micrograms is available in packs of 30x1 tablets in a precut unit dose blister.
The blisters are child-resistant.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Ferrer Internacional, S.A.
Gran Vía Carlos III, 94
08028 Barcelona
Spain
Manufacturer
Prasfarma, S.L.
C/ Sant Joan 11-15
08560 Manlleu - Barcelona
Spain
Local Representative
Ferrer Farma S.A.
Av. Diagonal 549, 5th floor
08029 Barcelona
Spain
Date of Last Revision of this Leaflet: April 2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of KAPTIC 100 micrograms SUBLINGUAL TABLETS in October, 2025 is around 30.16 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.